Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | KIT |
Variant | M552_E554delinsK |
Impact List | indel |
Protein Effect | gain of function - predicted |
Gene Variant Descriptions | KIT M552_E554delinsK results in a deletion of three amino acids in the juxtamembrane domain (exon 11) of the Kit protein from amino acids 552 to 554, combined with the insertion of a lysine (K) at the same site (PMID: 16226710). M552_E554delinsK has not been characterized, however similar Kit exon 11 deletions are activating (PMID: 9438854, PMID: 15365079), and therefore, is predicted to lead to a gain of Kit protein function. |
Associated Drug Resistance | |
Category Variants Paths |
KIT mutant KIT act mut KIT exon 11 del KIT M552_E554delinsK KIT mutant KIT exon11 KIT exon 11 del KIT M552_E554delinsK |
Transcript | NM_000222.3 |
gDNA | chr4:g.54727423_54727428delTGTATG |
cDNA | c.1655_1660delTGTATG |
Protein | p.M552_E554delinsK |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_017008178.1 | chr4:g.54727423_54727428delTGTATG | c.1655_1660delTGTATG | p.M552_E554delinsK | RefSeq | GRCh38/hg38 |
NM_000222.3 | chr4:g.54727423_54727428delTGTATG | c.1655_1660delTGTATG | p.M552_E554delinsK | RefSeq | GRCh38/hg38 |
XM_017008178 | chr4:g.54727423_54727428delTGTATG | c.1655_1660delTGTATG | p.M552_E554delinsK | RefSeq | GRCh38/hg38 |
NM_000222.2 | chr4:g.54727423_54727428delTGTATG | c.1655_1660delTGTATG | p.M552_E554delinsK | RefSeq | GRCh38/hg38 |
NM_001385285.1 | chr4:g.54727423_54727428delTGTATG | c.1655_1660delTGTATG | p.M552_E554delinsK | RefSeq | GRCh38/hg38 |
NM_000222 | chr4:g.54727423_54727428delTGTATG | c.1655_1660delTGTATG | p.M552_E554delinsK | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|